| Drug Name |
Ciclopirox |
| Drug ID |
BADD_D00461 |
| Description |
Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor. |
| Indications and Usage |
Used as a topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum. |
| Marketing Status |
approved; investigational |
| ATC Code |
D01AE14; G01AX12 |
| DrugBank ID |
DB01188
|
| KEGG ID |
D03488
|
| MeSH ID |
D000077768
|
| PubChem ID |
2749
|
| TTD Drug ID |
D07GRH
|
| NDC Product Code |
50090-6562; 63629-8620; 63629-8621; 68788-6797; 0574-2061; 0591-2159; 49706-1440; 99207-010; 51014-7851; 42192-714; 43538-500; 45802-141; 63629-8623; 42192-715; 50383-419; 51672-1351; 63629-8622; 68462-455; 64552-8110; 0713-0317; 17337-0506; 71052-661; 45802-401; 51672-1323; 51672-5302 |
| UNII |
19W019ZDRJ
|
| Synonyms |
Ciclopirox | Cyclopirox | HOE 296 | HOE-296 | HOE296 | Ciclopirox Olamine | Cyclopyroxolamine | 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt | Ciclopiroxolamine | Loprox | Batrafen | Penlac | Dafnegin-CSC | Dafnegin CSC |
